Indeed, the cannabis craze does appear to be dying down in recent months. But this doesn’t mean the sector no longer has potential. Perhaps it just means bigger isn’t always better when it comes to pot stocks.
Today, we look at the latest Elixinol news, along with recent announcements out of MGC and BOD. We conclude that Elixinol could encounter support in the coming weeks or months. Meanwhile, MGC and BOD remain exciting but more speculative cannabis plays.
At time of writing, the share price of MGC Pharmaceuticals Ltd [ASX:MXC] is holding steady at 5.3 cents. The company spiked in late in 2017, along with other ASX-listed cannabis companies...
Over the last six months MGC Pharmaceuticals Ltd’s [ASX:MXC] share price had been traveling pretty consistently, but since October shares of MGC have spiked.